0.00Open53.00Pre Close0 Volume0 Open Interest840.00Strike Price0.00Turnover3231.22%IV-2.86%PremiumJan 3, 2025Expiry Date74.90Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9452Delta0.0032Gamma14.44Leverage Ratio-2685.3089Theta0.0000Rho-13.64Eff Leverage0.0012Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet